Concepedia

High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers

Xue Hou, Yong Li, Rong Luo, Jianhan Fu, Jie He, Lan‐Jun Zhang, Haodong Yang

European Journal of Surgical Oncology · 2012 · 52 citations · 24 references

Concepts

MedicineMolecular GeneticsOncologyGene ExpressionMolecular OncologyTranscriptional RegulationCancer BiomarkersCancer Cell SignalingLung CancerMalignant NeoplasmsTranscription Factor OncogenesTumor Suppressor GenesLung AdenocarcinomaNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer Treatment

References

24

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Global Cancer Statistics, 2002

Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti et al. · Journal of Clinical Oncology · 2008 · 2.7K citations · Full text

Medicine, Oncology, Pharmacology +13

CBP/p300 in cell growth, transformation, and development

Richard H. Goodman, Sarah M. Smolik · Genes & Development · 2000 · 1.8K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Multiple primary lung cancers

Nael Martini, Myron R. Melamed · Journal of Thoracic and Cardiovascular Surgery · 1975 · 1.3K citations

Medicine, Oncology, Surgery +12